Nanjing Vishee Medical Technology Co., Ltd (SHA:688580)
China · Delayed Price · Currency is CNY 63.00
-0.50 (-0.79%)
Apr 30, 2026, 1:55 PM CST
SHA:688580 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 472.85 | 462.73 | 395.34 | 455.44 | 319.67 | 428.73 |
Other Revenue | - | - | 4.72 | 6.78 | 1.95 | 1.31 |
| 472.85 | 462.73 | 400.06 | 462.22 | 321.62 | 430.04 | |
Revenue Growth (YoY) | 15.81% | 15.66% | -13.45% | 43.72% | -25.21% | 13.66% |
Cost of Revenue | 3.9 | - | 138.26 | 149.16 | 88.52 | 108.45 |
Gross Profit | 468.95 | 462.73 | 261.8 | 313.06 | 233.1 | 321.59 |
Selling, General & Admin | 2.12 | - | 138.92 | 152.48 | 129.71 | 116.08 |
Research & Development | 1.12 | - | 50.61 | 57.65 | 43.73 | 63.52 |
Other Operating Expenses | 313.54 | 312.16 | -11.64 | -14.08 | -7.67 | -6.97 |
Operating Expenses | 316.78 | 312.16 | 179.33 | 198.31 | 166.29 | 173.52 |
Operating Income | 152.17 | 150.56 | 82.48 | 114.75 | 66.82 | 148.07 |
Interest Expense | -0.58 | - | -1.31 | -1.32 | -0.33 | -0.18 |
Interest & Investment Income | - | - | 21.11 | 29.9 | 35.29 | 37.35 |
Other Non Operating Income (Expenses) | 2.26 | 2.11 | 0.14 | 0.06 | -0.2 | -0.04 |
EBT Excluding Unusual Items | 153.85 | 152.67 | 102.42 | 143.39 | 101.57 | 185.2 |
Gain (Loss) on Sale of Investments | - | - | 2.42 | -0.96 | - | - |
Gain (Loss) on Sale of Assets | 32.14 | - | -0.01 | -0.01 | -0.01 | -0.01 |
Other Unusual Items | - | - | 8.45 | 7.6 | 4.29 | 12.19 |
Pretax Income | 185.99 | 152.67 | 113.28 | 150.01 | 105.84 | 197.38 |
Income Tax Expense | 21.01 | 16.04 | 11.31 | 13.75 | 12.01 | 19.84 |
Earnings From Continuing Operations | 164.99 | 136.63 | 101.97 | 136.26 | 93.83 | 177.54 |
Minority Interest in Earnings | - | - | - | - | - | 0.28 |
Net Income | 164.99 | 136.63 | 101.97 | 136.26 | 93.83 | 177.81 |
Net Income to Common | 164.99 | 136.63 | 101.97 | 136.26 | 93.83 | 177.81 |
Net Income Growth | 45.44% | 33.99% | -25.16% | 45.23% | -47.23% | 23.77% |
Shares Outstanding (Basic) | 96 | 96 | 95 | 96 | 96 | 96 |
Shares Outstanding (Diluted) | 96 | 96 | 95 | 96 | 96 | 96 |
Shares Change (YoY) | 0.56% | 0.12% | -0.29% | 0.05% | -0.31% | 17.41% |
EPS (Basic) | 1.72 | 1.43 | 1.07 | 1.43 | 0.98 | 1.86 |
EPS (Diluted) | 1.72 | 1.43 | 1.07 | 1.42 | 0.98 | 1.85 |
EPS Growth | 44.64% | 33.83% | -24.95% | 45.16% | -47.07% | 5.42% |
Free Cash Flow | - | - | 5.21 | 0.72 | -9.45 | 70.02 |
Free Cash Flow Per Share | - | - | 0.06 | 0.01 | -0.10 | 0.73 |
Dividend Per Share | - | - | 0.800 | 1.076 | 0.491 | 0.930 |
Dividend Growth | - | - | -25.62% | 119.02% | -47.19% | 23.87% |
Gross Margin | 99.17% | 100.00% | 65.44% | 67.73% | 72.48% | 74.78% |
Operating Margin | 32.18% | 32.54% | 20.62% | 24.82% | 20.77% | 34.43% |
Profit Margin | 34.89% | 29.53% | 25.49% | 29.48% | 29.17% | 41.35% |
Free Cash Flow Margin | - | - | 1.30% | 0.15% | -2.94% | 16.28% |
EBITDA | - | 170.65 | 102.56 | 133.69 | 82.77 | 157.96 |
EBITDA Margin | - | 36.88% | 25.64% | 28.92% | 25.74% | 36.73% |
D&A For EBITDA | - | 20.09 | 20.09 | 18.95 | 15.95 | 9.89 |
EBIT | 152.17 | 150.56 | 82.48 | 114.75 | 66.82 | 148.07 |
EBIT Margin | 32.18% | 32.54% | 20.62% | 24.82% | 20.77% | 34.43% |
Effective Tax Rate | 11.29% | 10.51% | 9.98% | 9.17% | 11.35% | 10.05% |
Revenue as Reported | - | - | 400.06 | 462.22 | 321.62 | 430.04 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.